Management of unstable angina at rest by verapamil. A double-blind cross-over study in coronary care unit.
AUTOR(ES)
Parodi, O
RESUMO
A therapeutic trial with verapamil, a calcium-antagonist drug, was performed in 12 patients admitted to our coronary care unit because of frequent daily attacks of angina at rest attributed to coronary vasospasm. After a 48-hour run-in period, oral verapamil 480 mg/day and placebo were administered alternately during 4 randomised 48-hour periods. Transient ischaemic attacks with ST segment elevation or depression, with or without pain, were documented by continuous electrocardiographic monitoring. The number of attacks during the run-in and 2 placebo periods were 128, 123, and 130, respectively, and 31 and 23 during the 2 treatment periods (P less than 0.006 and P less than 0.003). This drug therefore appears to be effective in the management of patients with frequent attacks of angina at rest.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=486844Documentos Relacionados
- A double-blind cross-over trial of trimethoprim and sulphamethoxazole in chronic bronchitis
- Double-blind cross-over comparison of indomethacin, flurbiprofen, and placebo in ankylosing spondylitis.
- Double-blind cross-over comparison of aceclidine and pilocarpine in open-angle glaucoma.
- Proceedings: Effects of natural oestrogens on blood clotting--a double-blind cross-over trial.
- A comparison of phenytoin and pheneturide in patients with epilepsy: a double-blind cross-over trial
